Meijer Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Meijer Pain Relief
Generic name: LIDOCAINE HCL 4%
Manufacturer: Meijer
Product type: HUMAN OTC DRUG
SPL set ID: f31b11ed-2ff9-5cfc-e053-2a95a90af2ca
SPL ID: 29b762dd-130f-def5-e063-6394a90a2b50
Version: 2
Effective date: 2024-12-20
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:45:00

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Meijer Pain Relief	openfda.brand_name
generic name		LIDOCAINE HCL 4%	openfda.generic_name
manufacturer name		Meijer	openfda.manufacturer_name
ndc	package	79481-1087-2	openfda.package_ndc
ndc	product	79481-1087	openfda.product_ndc
ndc11	package	79481108702	derived:openfda.package_ndc
rxcui		1010077	openfda.rxcui
spl id		29b762dd-130f-def5-e063-6394a90a2b50	id
spl set id		f31b11ed-2ff9-5cfc-e053-2a95a90af2ca	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Flammable-- Do not use while smoking or near heat or flame. When using this product avoid contact with eyes, do not apply to wounds or damaged skin, and do not bandage tightly. Stop use and ask a doctor if condition worsens, if symptoms persist for more than 7 days or clear up and occur again within a few days, redness or irritation develops.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.